Otsuka Pharmaceutical Development & Commercialization, Inc. is recalling 22,063 physician sample kits of treatNOW Abilify (aripiprazole) and Abilify Maintena (aripiprazole) due to significant labeling errors. The product name is misspelled on the packaging, critical storage instructions are missing, and the contents of the kits may be incorrectly identified on the outer carton. These kits were distributed nationwide across the United States as physician samples and are marked as 'not for sale.'
The lack of proper storage instructions and incorrect identification of kit contents could lead to improper handling of the medication or confusion regarding the dosage and components. This poses a risk of administering the medication incorrectly or using a product that has lost its effectiveness due to improper storage.
Healthcare provider consultation and pharmacy return
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.